Education
About Us
Working with TipRanks
Follow Us
Rapid Micro Biosystems (RPID)
NASDAQ:RPID
RPID Stock Chart & Stats
$3.05
-$0.03(-2.88%)
At close: 4:00 PM EST
$3.05
-$0.03(-2.88%)
Day’s Range― - ―
52-Week Range$0.87 - $4.50
Previous CloseN/A
Volume19.55K
Average Volume (3M)129.79K
Market Cap
$140.50M
Enterprise Value$133.01M
Total Cash (Recent Filing)$41.25M
Total Debt (Recent Filing)$24.11M
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Feb 27, 2026EPS Estimate
-0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding39,823,025
10 Day Avg. Volume151,953
30 Day Avg. Volume129,787
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)0.52
Price to Sales (P/S)1.40
P/FCF Ratio-0.86
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue4.36
Enterprise Value/Gross Profit23.72
Enterprise Value/Ebitda-3.21
Forecast
1Y Price Target
$8.00Price Target Upside162.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.99
Revenue Forecast (FY)$32.08M
Bulls Say, Bears Say
Bulls Say
Automation And Cost EfficiencyEach Growth Direct system can replace 2-3 full-time employees, providing substantial cost savings among competitors.
Earnings And GuidanceQ3 revenues beat and FY25 guidance raised to at least $33M off a record multi-system order of Growth Direct.
Market ExpansionMillipore Sigma order commitments, durable service/consumables revs, a strong funnel & US onshoring of manufacturing are solid tailwinds into FY26 and beyond.
Bears Say
Market ChallengesSpending uncertainty and tariff impact are driving expectations toward the lower end of 21-25 placements.
Rapid Micro Biosystems News
RPID FAQ
What was Rapid Micro Biosystems’s price range in the past 12 months?
Rapid Micro Biosystems lowest stock price was $0.87 and its highest was $4.50 in the past 12 months.
What is Rapid Micro Biosystems’s market cap?
Rapid Micro Biosystems’s market cap is $140.50M.
When is Rapid Micro Biosystems’s upcoming earnings report date?
Rapid Micro Biosystems’s upcoming earnings report date is Feb 27, 2026 which is in 64 days.
How were Rapid Micro Biosystems’s earnings last quarter?
Rapid Micro Biosystems released its earnings results on Nov 07, 2025. The company reported -$0.26 earnings per share for the quarter, missing the consensus estimate of -$0.245 by -$0.015.
Is Rapid Micro Biosystems overvalued?
According to Wall Street analysts Rapid Micro Biosystems’s price is currently Undervalued.
Does Rapid Micro Biosystems pay dividends?
Rapid Micro Biosystems does not currently pay dividends.
What is Rapid Micro Biosystems’s EPS estimate?
Rapid Micro Biosystems’s EPS estimate is -0.23.
How many shares outstanding does Rapid Micro Biosystems have?
Rapid Micro Biosystems has 39,823,025 shares outstanding.
What happened to Rapid Micro Biosystems’s price movement after its last earnings report?
Rapid Micro Biosystems reported an EPS of -$0.26 in its last earnings report, missing expectations of -$0.245. Following the earnings report the stock price went up 12.727%.
Which hedge fund is a major shareholder of Rapid Micro Biosystems?
Currently, no hedge funds are holding shares in RPID
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Rapid Micro Biosystems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.00 (162.30% Upside)
$8.00 (162.30% Upside)
Blogger Sentiment
Bullish
RPID Sentiment 100%
Sector Average 68%
Sector Average 68%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.0%
Last 30 Days ▼ 10.1%
Last 30 Days ▼ 10.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
234.79%
12-Months-Change
Fundamentals
Return on Equity
-68.83%
Trailing 12-Months
Asset Growth
-20.25%
Trailing 12-Months
Company Description
Rapid Micro Biosystems
Rapid Micro Biosystems (RPID) is a biotechnology company that specializes in providing innovative solutions for microbiological testing in the pharmaceutical, biotechnology, and personal care industries. The company focuses on transforming traditional microbiological testing processes through automation and advanced technologies, ensuring faster, more accurate results that enhance product safety and quality. RPID's core products include the Growth Direct System, which leverages advanced technology for rapid microbial detection and identification, streamlining the quality control processes in various sectors.
RPID Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted a significant multi-system order and strong revenue growth in consumables, underscoring the company's momentum and effective execution. However, challenges such as negative product margins and a net loss were also noted, with expectations of future improvements. The collaboration with MilliporeSigma is poised to enhance cost efficiencies and contribute to future growth.View all RPID earnings summariesRPID Stock 12 Month Forecast
Average Price Target
$8.00
▲(162.30% Upside)
Technical Analysis
Ownership Overview
4.98% Insiders
2.58% Mutual Funds
30.26% Other Institutional Investors
59.82% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---